Search Results for keywords:"cancer therapeutics"

The National Institutes of Health (NIH) has announced that multiple advisory committee meetings will be held regarding the review and evaluation of grant applications. All meetings will be conducted virtually and are closed to the public to protect confidential information and personal privacy. These meetings include various specialized groups focusing on topics such as cancer therapeutics, bioengineering, and population sciences. The meetings occur in March and April 2025, with detailed information available for each session, such as committee names, dates, times, agenda points, and contact persons.

The National Institutes of Health (NIH), under the Health and Human Services Department, is holding several closed meetings from February 13-14, 2025. These meetings will involve various committees, including those focusing on cancer therapeutics, healthcare delivery, neuroscience, and more. The purpose of these meetings is to review and evaluate grant applications, which contain sensitive information such as trade secrets and personal details, hence they will not be open to the public. The meetings will be held both in person, at a hotel in Washington, DC, and virtually at the NIH Rockledge location in Bethesda, MD.

The Center for Scientific Review at the National Institutes of Health announced several upcoming meetings concerning the evaluation of grant applications. These meetings will cover various scientific topics such as cancer therapeutics, neuroscience, endocrinology, epidemiology, and more. The meetings will be held virtually from March 3-5, 2021, and will be closed to the public to protect sensitive information. Participants are advised to note the specific details and contact information for each committee handling the review process.

The Center for Scientific Review announced several closed meetings to discuss grant applications. These meetings will be held virtually and discuss confidential information, including trade secrets and personal details, which is why they are not open to the public. The meetings will cover a range of topics, from cancer therapeutics to bioengineering sciences, and take place between March 24 and April 25, 2025. Each meeting will be led by a scientific review officer who is responsible for evaluating the applications.